These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2425438)

  • 1. [Inhibitors of hemostasis in diabetes mellitus].
    González R; Alegre A; Alberca I; Vicente V; López Borrasca A
    Sangre (Barc); 1986; 31(2):156-60. PubMed ID: 2425438
    [No Abstract]   [Full Text] [Related]  

  • 2. Components of the kallikrein-kinin-system in patients with ARDS.
    Fuhrer G; Heller W; Junginger W; Gröber O; Roth K
    Prog Clin Biol Res; 1989; 308():737-42. PubMed ID: 2476827
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional activities and nonenzymatic glycosylation of plasma proteinase inhibitors in diabetes.
    Hall P; Tryon E; Nikolai TF; Roberts RC
    Clin Chim Acta; 1986 Oct; 160(1):55-62. PubMed ID: 2429788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the imbalance between thrombin and plasmin activity in diabetes related to the behaviour of antiplasmin activity?
    Marongiu F; Conti M; Mameli G; Sorano GG; Cossu E; Cirillo R; Balestrieri A
    Thromb Res; 1990 Apr; 58(2):91-9. PubMed ID: 1693451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protease inhibitors].
    Lambin P
    Rev Fr Transfus Immunohematol; 1980 May; 23(2):147-83. PubMed ID: 6161406
    [No Abstract]   [Full Text] [Related]  

  • 6. Control mechanism of haemostasis--possible role of natural regulators.
    Nathan IV; Han P; Wong HB
    J Singapore Paediatr Soc; 1987; 29(3-4):176-9. PubMed ID: 2453736
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of plasma protease inhibitors and the secretory leucocyte protease inhibitor on leucocyte elastase-induced consumption of selected plasma proteins in vitro in man.
    Björk P; Axelsson L; Bergenfeldt M; Ohlsson K
    Scand J Clin Lab Invest; 1988 Apr; 48(2):205-11. PubMed ID: 2451859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum antithrombin III and alpha-2-antiplasmin concentrations in patients with Hodgkin's disease in the course of chemotherapy.
    Dabrowska M; Kemona H; Prokopowicz J; Kretowska J; Kiluk S
    Neoplasma; 1991; 38(3):249-52. PubMed ID: 1713303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monocytes release plasma serine protease inhibitors in vitro.
    Kłoczko J; Bielawiec M; Giedrojć J; Radziwon P; Galar M
    Haemostasis; 1990; 20(4):229-32. PubMed ID: 1700759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmin inhibitors in different fibrinolytic treatment patterns.
    Lasierra J; Diez M; Perera C; Viladés E
    Haemostasis; 1981; 10(1):51-62. PubMed ID: 6162721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of coagulation, atherosclerosis, and arterial thrombosis.
    Conard J; Samama MM
    Semin Thromb Hemost; 1986 Apr; 12(2):87-90. PubMed ID: 3755552
    [No Abstract]   [Full Text] [Related]  

  • 12. [Inhibitors of serum proteinases].
    Jendryczko A; Drózdz M
    Wiad Lek; 1985 Dec; 38(23):1654-9. PubMed ID: 2421489
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serial changes in protein C, antithrombin III, alpha 2-plasmin inhibitor, plasminogen and von Willebrand factor during the course of disseminated intravascular coagulation (DIC)].
    Takahashi H; Hanano M; Takizawa S; Tatewaki W; Fuse I; Satoh K; Wada K; Shibata A
    Rinsho Ketsueki; 1988 Mar; 29(3):336-43. PubMed ID: 3260969
    [No Abstract]   [Full Text] [Related]  

  • 14. Marine omega-3 fatty acids and atherosclerosis.
    Becker RC; Corrao JM
    Ann Intern Med; 1988 Apr; 108(4):641. PubMed ID: 2450503
    [No Abstract]   [Full Text] [Related]  

  • 15. The clinical value of glycated haemoglobin and glycated plasma proteins.
    Lester E
    Ann Clin Biochem; 1989 May; 26 ( Pt 3)():213-9. PubMed ID: 2669613
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in protein C inhibitor in disseminated intravascular coagulation: relationship with heparin cofactor II and alpha 2-plasmin inhibitor].
    Kazama Y; Takahashi K; Oguma Y; Sakuragawa N
    Rinsho Ketsueki; 1988 Mar; 29(3):344-8. PubMed ID: 3398266
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between antithrombin III, antiplasmin and plasma lipids in a healthy population.
    Scarabin PY; Bara L; Jacqueson A
    Thromb Haemost; 1983 Feb; 49(1):62. PubMed ID: 6845274
    [No Abstract]   [Full Text] [Related]  

  • 18. The coagulation and fibrinolytic enzyme system in pregnancy and in the puerperium.
    Beller FK; Ebert C
    Eur J Obstet Gynecol Reprod Biol; 1982 May; 13(3):177-97. PubMed ID: 6178627
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemostasis in burn patients and treatment with heparin. Relation to prognosis and infection. Pattern of blood levels of prekallikrein, alpha-2-macroglobulin, antithrombin III, plasminogen and alpha-2-antiplasmin].
    Hainaut J; Dhennin C; Guilbaud J
    Nouv Rev Fr Hematol (1978); 1982; 24(6):375-81. PubMed ID: 6188103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of graded hypothermia on coagulation and fibrinolysis.
    Staikou C; Paraskeva A; Drakos E; Anastassopoulou I; Papaioannou E; Donta I; Kontos M
    J Surg Res; 2011 May; 167(1):125-30. PubMed ID: 19932906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.